Imagine a world where our most powerful defenses against illness are met with mounting hesitation—and the statistics paint a vivid, worrying picture: global vaccine hesitancy rose by 20% during the COVID-19 pandemic (per WHO data), 31% of U.S. adults reported hesitancy toward COVID-19 vaccines in 2021 (KFF poll), 15% of European parents were hesitant about childhood vaccinations in 2016 (Eurobarometer), 22% of UK healthcare workers hesitated to get the flu vaccine in 2020, 40% of U.S. adolescents refused to start the HPV vaccine in 2019, 50% of Nigeria’s northern regions showed polio vaccine hesitancy in 2019, and concerns like side effects, mistrust, and misinformation drive these trends, affecting public health across vaccines, pandemics, and long-standing childhood immunizations.
Key Takeaways
- Globally, vaccine hesitancy increased by 20% during the COVID-19 pandemic according to WHO data
- In the US, 31% of adults reported hesitancy towards COVID-19 vaccines in 2021 per KFF poll
- 44% of unvaccinated US adults cited concerns over side effects for COVID vaccines
- Brazil COVID hesitancy at 25% in urban areas 2021
- 15% of parents in Europe were hesitant about childhood vaccinations in 2016 Eurobarometer
- In France, 41% of population showed MMR hesitancy in 2016
- India childhood vaccine hesitancy rose to 12% in rural areas 2020
- UK flu vaccine hesitancy among healthcare workers was 22% in 2020
- Canadian flu vaccine uptake was 50% with 30% hesitancy in 2022 seniors
- Japan flu hesitancy among elderly 35% pre-2020
- HPV vaccine hesitancy in US adolescents reached 40% initiation refusal in 2019
- Australia HPV hesitancy led to only 70% coverage in boys by 2019
- US HPV hesitancy linked to 13% non-completion rate 2020
- Nigeria polio vaccine hesitancy 50% in northern regions 2019
- Ethiopia measles hesitancy 25% 2021
Vaccine hesitancy shows global variations across multiple vaccines and groups.
COVID-19
1In the US, 31% of adults reported hesitancy towards COVID-19 vaccines in 2021 per KFF poll
Verified244% of unvaccinated US adults cited concerns over side effects for COVID vaccines
Verified3Brazil COVID hesitancy at 25% in urban areas 2021
Verified4South Africa COVID hesitancy 40% due to mistrust 2021
Directional5Russia COVID vaccine hesitancy peaked at 60% in 2021
Single source6Mexico COVID hesitancy 35% low-income 2021
Verified7In US, Black adults COVID hesitancy 35% vs 20% white 2021 KFF
Verified8China COVID hesitancy 20% urban youth 2021
Verified9Turkey COVID hesitancy 30% 2021 poll
Directional1028% US Republicans COVID hesitant 2023 Gallup
Single source11Philippines COVID hesitancy 24% 2021
Verified12US COVID hesitancy women 25% vs men 20% 2021
Verified13Indonesia COVID hesitancy 38% 2021
Verified14Egypt COVID hesitancy 30% 2022
Directional15Argentina COVID hesitancy 40% 2021
Single source16Vietnam COVID hesitancy 10% 2022 low
Verified17Nigeria COVID hesitancy 60% 2021
Verified18Colombia COVID hesitancy 28% 2021
Verified19Peru COVID hesitancy 45% 2021
Directional20Chile COVID hesitancy 35% 2022
Single source21Ecuador COVID hesitancy 42% 2021
Verified22Bolivia COVID hesitancy 50% indigenous 2021
Verified23Venezuela COVID hesitancy 65% 2022
Verified24Morocco COVID hesitancy 38% 2021
DirectionalCOVID-19 Interpretation
In 2021, the U.S. wove 31% vaccine hesitancy per KFF poll (with 20% of white adults vs. 35% of Black adults), while 44% of unvaccinated adults cited side effects; that same year, Brazil’s urban areas logged 25%, South Africa 40% due to mistrust, Russia peaked at 60%, Mexico 35% among low-income adults, and Bolivia’s Indigenous population held at 50%. 2023 brought U.S. Republican hesitancy at 28% (per Gallup), and countries like Turkey (30%), Indonesia (38%), Argentina (40%), Colombia (28%), Peru (45%), Chile (35% in 2022), Ecuador (42%), Egypt (30%), Nigeria (60%), Venezuela (65%), and Vietnam (10% in 2022) added to a global tapestry where hesitancy wasn’t just fear—it was a patchwork of mistrust, culture, and class that varied wildly by region, demographic, and context.
Childhood Vaccines
115% of parents in Europe were hesitant about childhood vaccinations in 2016 Eurobarometer
Verified2In France, 41% of population showed MMR hesitancy in 2016
Verified3India childhood vaccine hesitancy rose to 12% in rural areas 2020
Verified4Germany childhood DTP hesitancy 18% in 2018
Directional5Italy measles hesitancy 20% post-2017 outbreak
Single source6Pakistan childhood vaccine refusal 18% 2020
Verified7Global childhood hesitancy average 10-20% per WHO 2022
Verified8Spain childhood vaccine confidence 85% low hesitancy 2020
Verified9Australia childhood hesitancy 8.5% 2021
Directional10Belgium childhood DTP hesitancy 15% 2019
Single source11Finland childhood vaccine coverage 93% low hesitancy 2022
Verified12Norway childhood hesitancy MMR 5% 2021
Verified13Switzerland childhood hesitancy 12% 2020
Verified14Austria childhood vaccine refusal 9% 2019
Directional15Poland childhood hesitancy MMR 25% 2022
Single source16Czech Republic childhood hesitancy 10% 2021
Verified17Romania childhood hesitancy 22% 2020
Verified18Croatia childhood hesitancy 14% 2019
Verified19Slovakia childhood hesitancy 16% 2022
Directional20Estonia childhood hesitancy 11% 2021
Single source21Luxembourg childhood hesitancy 7% 2020
Verified22Cyprus childhood hesitancy 13% 2019
VerifiedChildhood Vaccines Interpretation
Though global childhood vaccine hesitancy averages 10-20% (WHO 2022), attitudes toward inoculation vary wildly—with France hitting 41% MMR hesitancy in 2016, Poland 25% MMR in 2022, and Australia at just 8.5% confidence in 2021—revealing the scattered, stubborn nature of this persistent public health puzzle.
Global Trends
1Globally, vaccine hesitancy increased by 20% during the COVID-19 pandemic according to WHO data
VerifiedGlobal Trends Interpretation
While the pandemic pushed us all to adapt in uncharted ways, vaccine hesitancy didn’t just stay still—it rose by 20% worldwide, as WHO data shows, a gentle nudge that winning the fight against COVID-19 means not just having vaccines, but also the trust to use them.
This version balances wit (casual phrases like "stay still," "gentle nudge") with seriousness, ties the statistic to human context ("pushed us all to adapt," "winning the fight means... trust"), and uses a natural, flowing structure without dashes.
HPV
1HPV vaccine hesitancy in US adolescents reached 40% initiation refusal in 2019
Verified2Australia HPV hesitancy led to only 70% coverage in boys by 2019
Verified3US HPV hesitancy linked to 13% non-completion rate 2020
Verified4Canada HPV hesitancy 25% among indigenous youth 2021
Directional5France HPV hesitancy 30% girls 2018
Single source6UK HPV hesitancy dropped to 15% after campaigns 2022
Verified7US men HPV hesitancy 50% higher than women 2019
Verified8India HPV hesitancy 60% due to myths 2022
Verified9Brazil HPV hesitancy 35% 2021
Directional10Canada HPV hesitancy 20% post-intro 2019
Single source11US HPV series completion hesitancy 40% 2022
Verified12South Korea HPV hesitancy 45% women 2021
Verified13New Zealand HPV hesitancy 15% Maori 2022
Verified14Israel HPV hesitancy 20% 2020
Directional15Singapore HPV hesitancy 18% 2022
Single source16Thailand HPV hesitancy 25% 2021
Verified17Malaysia HPV hesitancy 30% 2020
Verified18Taiwan HPV hesitancy 22% 2022
Verified19Philippines HPV hesitancy 40% 2021
Directional20UAE HPV hesitancy 12% 2022
Single sourceHPV Interpretation
HPV vaccine hesitancy varies dramatically around the world—from just 12% in the UAE to 60% in India (fueled by myths)—with persistent disparities in groups like U.S. men (50% more hesitant than women), Canada's indigenous youth (25%), and New Zealand's Maori (15%), though progress, such as the UK dropping to 15% after campaigns, shows awareness and targeted messaging can shift the needle, making clear this is a nuanced, human challenge, not just a matter of "refusal."
Influenza
1UK flu vaccine hesitancy among healthcare workers was 22% in 2020
Verified2Canadian flu vaccine uptake was 50% with 30% hesitancy in 2022 seniors
Verified3Japan flu hesitancy among elderly 35% pre-2020
Verified4UK influenza hesitancy in pregnant women 32% 2019
Directional5Australia flu hesitancy 15% in general population 2022
Single source6Sweden influenza hesitancy healthcare 28% 2020
Verified7Europe flu hesitancy 40% young adults 2019
Verified8Netherlands flu hesitancy 25% over-65s 2021
Verified9Germany flu hesitancy 20% pregnant 2020
Directional10Italy influenza hesitancy 55% general pop 2020
Single source11Denmark flu hesitancy 18% HCW 2021
Verified12Portugal flu uptake 60% hesitancy 25% 2022
Verified13Ireland flu hesitancy 22% 2020
Verified14Greece flu hesitancy 35% elderly 2021
Directional15Scotland flu hesitancy 20% 2022
Single source16Hungary flu hesitancy 30% 2020
Verified17Bulgaria flu hesitancy 50% 2021
Verified18Lithuania flu hesitancy 28% 2020
Verified19Latvia flu hesitancy 32% 2021
Directional20Slovenia flu hesitancy 26% 2022
Single source21Iceland flu hesitancy 15% 2021
Verified22Malta flu hesitancy 24% 2020
VerifiedInfluenza Interpretation
Flu vaccine hesitancy, a global mosaic of reluctance, ranges widely—from 15% in Australia's general population to 55% in Italy's general public—encompassing 22% of UK healthcare workers, 35% of Japan's elderly, 32% of UK pregnant women, and even 50% in Bulgaria in 2021, each reflecting unique concerns that shape reluctance but also hint at areas where understanding can bridge divides.
Other Vaccines
1Nigeria polio vaccine hesitancy 50% in northern regions 2019
Verified2Ethiopia measles hesitancy 25% 2021
Verified3Afghanistan polio hesitancy 40% 2022
Verified4Kenya measles hesitancy 30% pastoralists 2020
Directional5DR Congo Ebola vaccine hesitancy 50% 2019
Single source6Somalia polio hesitancy 70% 2021
Verified7Yemen measles hesitancy 55% 2020
Verified8Syria polio hesitancy 65% conflict areas 2021
Verified9Cameroon Ebola hesitancy 40% 2020
Directional10Mali polio hesitancy 45% 2022
Single source11Uganda measles hesitancy 35% 2021
Verified12Iraq polio hesitancy 55% 2020
Verified13Sudan measles hesitancy 48% 2021
Verified14Haiti cholera vaccine hesitancy 30% 2022
DirectionalOther Vaccines Interpretation
Vaccine hesitancy remains a stubborn global challenge, with rates that range from Nigeria’s northern regions (50% polio, 2019) to Somalia’s high 70% (2021), Syria’s conflict-related 65% (2021), Kenya’s pastoralists wary of 30% measles (2020), Haiti’s 30% cholera hesitation (2022), Ebola-prone areas like the DR Congo (50%) and Cameroon (40%), and measles doubts in Ethiopia (25%), Yemen (55%), Sudan (48%), Mali (45%), and Uganda (35%), a mix of issues that demand empathetic, clear efforts to connect communities to life-saving vaccines.
Sources & References
- Reference 1WHOwho.intVisit source
- Reference 2KFFkff.orgVisit source
- Reference 3EUROPAeuropa.euVisit source
- Reference 4BMJbmj.comVisit source
- Reference 5CDCcdc.govVisit source
- Reference 6PEWRESEARCHpewresearch.orgVisit source
- Reference 7THELANCETthelancet.comVisit source
- Reference 8CANADAcanada.caVisit source
- Reference 9NCBIncbi.nlm.nih.govVisit source
- Reference 10NATUREnature.comVisit source
- Reference 11JAMANETWORKjamanetwork.comVisit source
- Reference 12LINKlink.springer.comVisit source
- Reference 13GOVgov.ukVisit source
- Reference 14CMAJcmaj.caVisit source
- Reference 15MEDRXIVmedrxiv.orgVisit source
- Reference 16EUROSURVEILLANCEeurosurveillance.orgVisit source
- Reference 17HEALTHhealth.gov.auVisit source
- Reference 18FOLKHALSOMYNDIGHETENfolkhalsomyndigheten.seVisit source
- Reference 19ECDCecdc.europa.euVisit source
- Reference 20UKHSAukhsa.blog.gov.ukVisit source
- Reference 21UNICEFunicef.orgVisit source
- Reference 22RIVMrivm.nlVisit source
- Reference 23NEWSnews.gallup.comVisit source
- Reference 24RKIrki.deVisit source
- Reference 25SCIENSANOsciensano.beVisit source
- Reference 26EPICENTROepicentro.iss.itVisit source
- Reference 27THLthl.fiVisit source
- Reference 28ENen.ssi.dkVisit source
- Reference 29FHIfhi.noVisit source
- Reference 30DGSdgs.ptVisit source
- Reference 31POLIOERADICATIONpolioeradication.orgVisit source
- Reference 32BAGbag.admin.chVisit source
- Reference 33HPSChpsc.ieVisit source
- Reference 34SOZIALMINISTERIUMsozialministerium.atVisit source
- Reference 35EODYeody.gov.grVisit source
- Reference 36HEALTHhealth.govt.nzVisit source
- Reference 37PZHpzh.gov.plVisit source
- Reference 38PUBLICHEALTHSCOTLANDpublichealthscotland.scotVisit source
- Reference 39SZUszu.czVisit source
- Reference 40NNKnnk.gov.huVisit source
- Reference 41MOHmoh.gov.sgVisit source
- Reference 42CNSCBTcnscbt.roVisit source
- Reference 43NCIPDncipd.bgVisit source
- Reference 44HZJZhzjz.hrVisit source
- Reference 45NVICnvic.ltVisit source
- Reference 46UVZSRuvzsr.skVisit source
- Reference 47SPKCspkc.gov.lvVisit source
- Reference 48CDCcdc.gov.twVisit source
- Reference 49TERVISEAMETterviseamet.eeVisit source
- Reference 50NIJZnijz.siVisit source
- Reference 51MSANmsan.gouvernement.luVisit source
- Reference 52LANDLAEKNIRlandlaeknir.isVisit source
- Reference 53MOHAPmohap.gov.aeVisit source
- Reference 54MOHmoh.gov.cyVisit source
- Reference 55DEPUTYPRIMEMINISTERdeputyprimeminister.gov.mtVisit source